{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T23:31:26Z","timestamp":1794871886617,"version":"4.9.1"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,1,12]],"date-time":"2025-01-12T00:00:00Z","timestamp":1736640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To describe the clinical profile and compare the long-term outcomes of patients with systemic polyarteritis nodosa (S-PAN) treated with various treatment regimens at our centre in the last two decades.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data regarding clinical presentation, treatment allocation, relapses and outcomes of patients fulfilling American College of Rheumatology (ACR) 1990 criteria for PAN in the last two decades were recorded from electronic medical records. Relapse-free survival and predictors were analysed using Kaplan\u2013Meier survival statistics and regression analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Altogether, 53 patients, including two with hepatitis B infection, were included. Cutaneous lesions and peripheral neuropathy were the commonest manifestations. Most patients (64.2%) presented with a five-factor score (FFS) of 0. Disease-attributable hypertension and peripheral gangrene were the most common manifestations of severe disease. During a median follow-up period of 53.5\u2009months in 49 patients who had a follow up, 43 (87.8%) attained complete response while 3 (6.1%) had a partial response. Among 46 patients who had follow up of more than 3 months, 19 (41.3%) patients relapsed at a median duration of 82 (interquartile range 36.3\u2013127.7) months. The relapse-free survival in patients who received induction with mycophenolate (n\u2009=\u200926) was comparable to that with cyclophosphamide (n\u2009=\u200921) [adjusted hazard ratio (HR): 0.68]. Smoking history was an independent predictor of relapse (HR\u2009=\u20096.28, P\u2009=\u20090.013) while age was protective (HR\u2009=\u20090.94, P\u2009=\u20090.015). Overall, fatality was observed in 5 (10%) patients. FFS and BVAS at 3\u2009months were among the predictors of mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In our cohort of S-PAN, relapses were observed in 41.3% of patients. Mycophenolate was similar to cyclophosphamide in maintaining relapse-free survival. Only 10% fatality was recorded. FFS and BVAS at 3\u2009months were predictors of mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaf014","type":"journal-article","created":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T07:13:46Z","timestamp":1736579626000},"page":"3710-3717","source":"Crossref","is-referenced-by-count":2,"title":["The clinical characteristics and treatment outcomes of patients with systemic polyarteritis nodosa: a single-centre study from India"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3495-0827","authenticated-orcid":false,"given":"Avanish","family":"Jha","sequence":"first","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Christian Medical College , Vellore,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitra","family":"R","sequence":"additional","affiliation":[{"name":"Department of General Pathology, Christian Medical College , Vellore,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijesh","family":"Yadav","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Christian Medical College , Vellore,","place":["India"]},{"name":"Department of Biostatistics, King Abdullah International Medical Research Centre , Riyadh,","place":["Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty","family":"Simon","sequence":"additional","affiliation":[{"name":"Department of Radiodiagnosis, Christian Medical College , Vellore,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2061-2042","authenticated-orcid":false,"given":"Ashish J","family":"Mathew","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Christian Medical College , Vellore,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Mathew","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Christian Medical College , Vellore,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of General Pathology, Christian Medical College , Vellore,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3127-6777","authenticated-orcid":false,"given":"Ruchika","family":"Goel","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Christian Medical College , Vellore,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,1,12]]},"reference":[{"key":"2025052703534685200_keaf014-B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 Revised International Chapel Hill Consensus Conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":". Arthritis Rheum"},{"key":"2025052703534685200_keaf014-B2","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/rheumatology\/kel091","article-title":"Polyarteritis nodosa when applying the Chapel Hill nomenclature\u2014a descriptive study on ten patients","volume":"45","author":"Selga","year":"2006","journal-title":"Rheumatology"},{"key":"2025052703534685200_keaf014-B3","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/art.11115","article-title":"The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions","volume":"49","author":"Gonzalez-Gay","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2025052703534685200_keaf014-B4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0002-9343(67)90144-1","article-title":"Long-term follow-up study of periarteritis nodosa","volume":"43","author":"Frohnert","year":"1967","journal-title":"Am J Med"},{"key":"2025052703534685200_keaf014-B5","doi-asserted-by":"crossref","first-page":"103093","DOI":"10.1016\/j.jaut.2023.103093","article-title":"Clinical features and long-term outcomes of patients with systemic polyarteritis nodosa diagnosed since 2005: data from 196 patients","volume":"139","author":"Rohmer","year":"2023","journal-title":"J Autoimmun"},{"key":"2025052703534685200_keaf014-B6","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A","article-title":"Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients","volume":"44","author":"Gayraud","year":"2001","journal-title":"Arthritis Rheum"},{"key":"2025052703534685200_keaf014-B7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/art.10922","article-title":"Treatment of Polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients","volume":"49","author":"Guillevin","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2025052703534685200_keaf014-B8","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/art.1780330805","article-title":"The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa","volume":"33","author":"Lightfoot","year":"1990","journal-title":"Arthritis Rheum"},{"key":"2025052703534685200_keaf014-B9","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/art.27240","article-title":"Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database","volume":"62","author":"Pagnoux","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2025052703534685200_keaf014-B10","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2008.101279","article-title":"Modification and validation of the Birmingham Vasculitis Activity Score (version 3)","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2025052703534685200_keaf014-B11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/art.1780400222","article-title":"Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides","volume":"40","author":"Exley","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2025052703534685200_keaf014-B12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00005792-199601000-00003","article-title":"Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients","volume":"75","author":"Guillevin","year":"1996","journal-title":"Medicine (Baltimore)"},{"key":"2025052703534685200_keaf014-B13","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/art.42817","article-title":"Clinical characteristics and outcomes of polyarteritis nodosa: an international study","volume":"76","author":"Karadag","year":"2024","journal-title":"Arthritis Rheumatol (Hoboken, N.J.)"},{"key":"2025052703534685200_keaf014-B14","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3346\/jkms.2006.21.4.591","article-title":"Clinical features of polyarteritis nodosa in Korea","volume":"21","author":"Bae","year":"2006","journal-title":"J Korean Med Sci"},{"key":"2025052703534685200_keaf014-B15","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/1756-185X.12954","article-title":"Polyarteritis nodosa in north India: clinical manifestations and outcomes","volume":"20","author":"Sharma","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"2025052703534685200_keaf014-B16","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/1756-185X.13120","article-title":"Comparing polyarteritis nodosa in children and adults: a single center study","volume":"20","author":"Erden","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"2025052703534685200_keaf014-B17","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/art.33361","article-title":"Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"64","author":"Walsh","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2025052703534685200_keaf014-B18","first-page":"361","article-title":"Smoking is a risk factor for relapse of antimyeloperoxidase antibodies-associated vasculitis","volume":"24","author":"Yamaguchi","year":"2018","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"key":"2025052703534685200_keaf014-B19","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1038\/s41440-023-01455-z","article-title":"Smoking cessation and vascular endothelial function","volume":"46","author":"Higashi","year":"2023","journal-title":"Hypertens Res"},{"key":"2025052703534685200_keaf014-B20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3109\/14397595.2016.1172999","article-title":"Imbalanced expression of dysfunctional regulatory T cells and T-helper cells relates to immunopathogenesis in polyarteritis nodosa","volume":"27","author":"Shimojima","year":"2017","journal-title":"Mod Rheumatol"},{"key":"2025052703534685200_keaf014-B21","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/art.1780370711","article-title":"Immunohistochemical characterization of inflammatory cells and immunologic activation markers in muscle and nerve biopsy specimens from patients with systemic polyarteritis nodosa","volume":"37","author":"Cid","year":"1994","journal-title":"Arthritis Rheum"},{"key":"2025052703534685200_keaf014-B22","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00005792-199509000-00002","article-title":"Polyarteritis nodosa related to hepatitis B virus A prospective study with long-term observation of 41 patients","volume":"74","author":"Guillevin","year":"1995","journal-title":"Medicine (Baltimore)"},{"key":"2025052703534685200_keaf014-B23","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/art.41730","article-title":"Mycophenolate mofetil versus cyclophosphamide for remission induction in childhood polyarteritis nodosa: an open-label, randomized, Bayesian noninferiority trial","volume":"73","author":"Brogan","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2025052703534685200_keaf014-B24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/ard-2022-223764","article-title":"EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update","volume":"83","author":"Hellmich","year":"2024","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaf014\/61416332\/keaf014.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/6\/3710\/61416332\/keaf014.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/6\/3710\/61416332\/keaf014.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T03:54:00Z","timestamp":1748318040000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/6\/3710\/7952025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,12]]},"references-count":24,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,1,12]]},"published-print":{"date-parts":[[2025,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaf014","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2025,1,12]]}}}